H.C. Wainwright Raises the PT on ​CorMedix Inc. (CRMD), Keeps a Buy

​CorMedix Inc. (NASDAQ:CRMD) is one of the Fast-Growing Small Cap Stocks to Buy According to Analysts. On November 13, H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating on CorMedix Inc. (NASDAQ:CRMD) and raised the price target from $17 to $18. The improved positive outlook follows the company’s earnings beat during its fiscal Q3 2025. ​CorMedix Inc. (NASDAQ:CRMD) released fiscal Q3 2025 results on November 12. The revenue for the quarter grew 810.21% year-over-year to $104.28 million, surpas ...